Femoral and Obturator Nerve Articular Branches Prf

September 24, 2025 updated by: Damla Yürük, Diskapi Teaching and Research Hospital

A Study on the Effectiveness of Pulsed Radiofrequency Treatment Applied to the Femoral and Obturator Nerve Articular Branches Under Ultrasound Guidance in Chronic Hip Osteoarthritis

In our clinic, patients undergoing pulsed radiofrequency treatment of the femoral and obturator nerve articular branches under ultrasound guidance for pain management due to hip and groin pain associated with hip osteoarthritis will have the efficacy of these methods on pain compared with the Numeric Rating Scale (NRS) and Oxford Hip Score (OHS) at 2, 6, 12 weeks.

Study Overview

Detailed Description

Osteoarthritis of the hip joint is a common cause of pain and disability. Patients who do not respond to conservative treatments such as painkillers, physical therapy, and exercise often cannot undergo joint replacement due to comorbid conditions, while some patients prefer to postpone surgery as long as possible. Pulsed radiofrequency treatment applied to the articular branches of the femoral and obturator nerves, which innervate the joint, is a new technique for reducing hip joint pain. Previous studies have reported positive results after applying thermal neurolytic radiofrequency to the target nerves; however, this approach carries the risk of neuritis and neuroma formation. In our study, we aimed to investigate the effectiveness of pRF treatment applied to the articular branches of the femoral and obturator nerves under ultrasound guidance on pain and functionality in patients with chronic hip pain associated with osteoarthritis. The fact that the procedure is performed under ultrasound guidance, does not involve radiation exposure, and is an accessible and easy-to-perform technique makes it preferable for both patients and physicians.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Ankara, Turkey (Türkiye)
        • Recruiting
        • Ankara Etlik City Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 1. Patients with hip and groin pain who have been diagnosed with hip osteoarthritis by direct radiography
  • 2. Patients who have had hip pain above VAS 5 for more than 6 weeks
  • 3. Failure of pain treatment with conservative methods such as analgesics and physical therapy

Exclusion Criteria:

  • 1. Patients with lumbar radiculopathy and axial back pain, sacroiliac joint, connective tissue disease
  • 2. Patients who do not attend follow-up appointments regularly or cannot be reached by phone
  • 3. Patients who started additional analgesic medication or underwent additional interventional procedures after the initial interventional procedure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: pulsed radiofrequency group
femoral and obturator nerve articular branches pulsed radiofrequency for hip osteoartritis

Hemodynamic monitoring is provided. The hip joint where the procedure will be performed is cleaned with povidone-iodine. Sterile draping is performed. For PRF application to the articular branches of the femoral nerve, a convex ultrasound probe is first used to locate the articular branches of the femoral nerve in the groin area, followed by the articular branches of the obturator nerve. The radiofrequency cannula is inserted sequentially into the target points and sensory feedback is obtained. Then, a pulsed radiofrequency current, which has therapeutic properties for chronic pain and does not damage tissues by exceeding a temperature of 42 degrees, is applied to the relevant nerve root for 240 seconds. Subsequently, an injectate consisting of 2 cc of 5% bupivacaine, 4 mg of dexamethasone, and 2 cc of physiological saline is administered to the same nerve.

Translated with DeepL.com (free version)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
numeric rating scale
Time Frame: Change from baseline to 2nd 6 th and 12th weeks after treatment
The numeric rating scale (NRS) is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"
Change from baseline to 2nd 6 th and 12th weeks after treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
oxford hip score
Time Frame: Change from baseline to 2nd 6th and 12th weeks after treatment
The Oxford Hip Score (OHS) is a joint-specific, patient-reported outcome measure designed to assess disability in patients witth hip osteoarthritis
Change from baseline to 2nd 6th and 12th weeks after treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Gevher Rabia Genc Perdecioğlu, Diskapi TRH

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 20, 2025

Primary Completion (Estimated)

April 20, 2026

Study Completion (Estimated)

August 20, 2026

Study Registration Dates

First Submitted

September 17, 2025

First Submitted That Met QC Criteria

September 17, 2025

First Posted (Estimated)

September 24, 2025

Study Record Updates

Last Update Posted (Estimated)

September 30, 2025

Last Update Submitted That Met QC Criteria

September 24, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • hip pericapsular nerve pRF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Ostearthritis

Clinical Trials on ultrasound-guided femoral and obturator nerve articular branches pulsed radiofrequency

3
Subscribe